Status:
RECRUITING
Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection
Lead Sponsor:
Xiangya Hospital of Central South University
Collaborating Sponsors:
The First Medical Center of Chinese PLA General Hospital
West China Hospital
Conditions:
Spontaneous Isolated Superior Mesenteric Artery Dissection
Eligibility:
All Genders
18+ years
Brief Summary
Spontaneous isolated superior mesenteric artery dissection(SISMAD) is an increasingly diagnosed disease. However, prospective, multicenter studies that can provide evidence to support clinical decisio...
Eligibility Criteria
Inclusion
- Aged 18 and above;
- Isolated superior mesenteric artery dissection with clear symptoms or history and confirmed by CTA
- Signed informed consent forms, willing to receive treatments
Exclusion
- Symptoms are severe and patients need exploratory laparotomy;
- Patients with aortic dissection, iliac artery dissection, or autoimmune vasculitis;
- Patients with mental illness cannot cooperate subjectively;
- Patients who are allergic to contrast agents, or contraindicated to conservative treatment drugs, and cannot be treated with drugs;
- Pregnancy and breastfeeding women, or patients who have recent birth plans;
- Patients who are participating in other clinical projects;
- Patients are not suitable to participate in this study.
Key Trial Info
Start Date :
April 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05342233
Start Date
April 30 2022
End Date
April 1 2028
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiangya Hospital of Central South University
Changsha, Hunan, China